Glycomed Inc. has promoted Brian G. Atwood, a companyfounder, to senior vice president of operations. Atwood hadbeen vice president of operations since July 1988. Glycomed(NASDAQ:GLYC) of Alameda, Calif., develops complexcarbohydrates for use in cardiovascular and inflammatorydiseases and tissue repair.
Epitope Inc. has elected Richard K. Donahue, president and chiefoperating officer of Nike Inc., to its board. Epitope (AMEX:EPT)of Beaverton, Ore., is developing diagnostics for AIDS and otherindications, therapeutic anti-microbial drugs, and, through itsAgritope Inc. unit, new plant varieties.
Marrow-Tech Inc. of La Jolla, Calif., has hired E. Walter Langeas marketing planning and development consultant to work onthe launch of its Dermagraft therapeutic. Lange recentlyretired as group vice president of worldwide marketingplanning and development at Eli Lilly & Co. Marrow-Tech(NASDAQ:MAROA) is engaged in the growth of human tissueoutside the body.
David I. Gwynne, Ph.D., has been appointed to the new positionof director of biotechnology at Cambridge Neuroscience Inc.Gwynne was director of scientific affairs and manager ofexploratory projects at Allelix Biopharmaceuticals Inc.Cambridge Neurosciences (NASDAQ:CNSI) of Cambridge, Mass.,is developing treatments for neurological and psychiatricdisorders.
New board members at Cytel Corp. of San Diego are Dr. StanleyCrooke, Ph.D., chairman and chief executive officer of IsisPharmaceuticals Inc., and Gavin S. Herbert, chairman and CEOof Allergan Inc. Privately held Cytel designs small-moleculedrugs aimed at controlling the interactions between immunereceptors and their target cells.
Clinical Technologies Associates Inc. of Elmsford, N.Y., hasappointed Robert A. Baughman Jr., Ph.D., vice president anddirector of research and development. Baughman had beendirector of preclinical pharmaceutical development forCholestech Corp. Clinical Technologies Associates(NASDAQ:CTAI) is developing oral drug-delivery technology.
Abraham Grossman, Ph.D., has been appointed director ofreference laboratories for Collaborative Research Inc.'sdiagnostic services division. Grossman was previously directorof cancer testing at Lifecodes Corp. Collaborative Researchalso named John Richard vice president of sales and marketingfor the diagnostic services division. Richard was founder andpresident of Impath Labs. Collaborative Research(NASDAQ:CRIC) of Bedford, Mass., develops DNA probes.
(c) 1997 American Health Consultants. All rights reserved.